{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T12:05:26Z","timestamp":1746446726892,"version":"3.30.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.revmed.2024.07.008","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T11:58:51Z","timestamp":1723031931000},"page":"759-766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Le syndrome d\u2019hyperviscosit\u00e9 s\u00e9rique\u00a0: mise au point en 2024"],"prefix":"10.1016","volume":"45","author":[{"given":"Pierre-Edouard","family":"Debureaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Parquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne C.","family":"Brignier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dikelele","family":"Elessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Lemiale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Siguret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Antoine","family":"Quintard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Harel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Royer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Arnulf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2024.07.008_bib0245","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM197007232830406","article-title":"Syndromes of Hyperviscosity","author":"Wells","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2024.07.008_bib0250","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2024.07.008_bib0255","first-page":"e2021193","article-title":"Priapism in Patients with Chronic Myeloid Leukemia (CML): A Systematic Review","volume":"92","author":"Ali","year":"2021","journal-title":"Acta Biomed"},{"key":"10.1016\/j.revmed.2024.07.008_bib0260","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/CH-2008-1088","article-title":"Plasma viscosity: A forgotten variable","volume":"39","author":"K\u00e9sm\u00e1rky","year":"2008","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.revmed.2024.07.008_bib0265","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3389\/fonc.2020.00815","article-title":"Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia","volume":"10","author":"Weaver","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.revmed.2024.07.008_bib0270","doi-asserted-by":"crossref","unstructured":"Reisman Ha. Hyperproteinaemia as a cause of autohaemagglutination. 1932:1411.","DOI":"10.1001\/jama.1932.02740690021007"},{"key":"10.1016\/j.revmed.2024.07.008_bib0275","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.0954-6820.1944.tb03955.x","article-title":"Incipient myelomatosis or \u201cessential\u201d hyperglobnlinemia with fibrino-genopenia-a new syndrome?","volume":"117","author":"Waldenstrom","year":"1944","journal-title":"Acta Medica Scandinavica"},{"key":"10.1016\/j.revmed.2024.07.008_bib0280","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.1965.03080190030008","article-title":"Serum Hyperviscosity Syndrome","volume":"192","author":"Fahey","year":"1965","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2024.07.008_bib0285","doi-asserted-by":"crossref","first-page":"853","DOI":"10.7326\/0003-4819-77-6-853","article-title":"Serum Viscosity and Hyperviscosity Syndrome in IgG Multiple Myeloma: Report on 10\u00a0Patients and a Review of the Literature","volume":"77","author":"Pruzanski","year":"1972","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2024.07.008_bib0290","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1055\/s-2003-44554","article-title":"Hyperviscosity syndrome in plasma cell dyscrasias","volume":"29","author":"Mehta","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.revmed.2024.07.008_bib0295","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/ajh.25254","article-title":"Predictors of symptomatic hyperviscosity in Waldenstr\u00f6m macroglobulinemia","volume":"93","author":"Abeykoon","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2024.07.008_bib0300","first-page":"13","article-title":"Prognosis of hyperviscosity syndrome in newly diagnosed multiple myeloma in modern-era therapy: A real-life study","author":"Debureaux","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2024.07.008_bib0305","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archopht.124.11.1601","article-title":"Hyperviscosity-Related Retinopathy in Waldenstr\u00f6m Macroglobulinemia","volume":"124","author":"Menke","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.revmed.2024.07.008_bib0310","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0002-9394(70)90894-9","article-title":"Retinal Circulation in the Hyperviscosity Syndrome","volume":"70","author":"Luxenberg","year":"1970","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2024.07.008_bib0315","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2147\/JBM.S424072","article-title":"Hyperviscosity Syndrome Induced Bilateral Visual and Auditory Impairment in Therapy Resistant Waldenstr\u00f6m Macroglobulinemia with MYD88\u00a0and CXCR4\u00a0Mutations","volume":"14","author":"Plante","year":"2023","journal-title":"J Blood Med"},{"key":"10.1016\/j.revmed.2024.07.008_bib0320","unstructured":"College of American Pathologists: VA & VB Participant. - Google Scholar n.d. https:\/\/scholar.google.com\/scholar_lookup?title=2010\u00a0%C2\u00a0%A0V-A%20\u00a0%26\u00a0%20V-B%20Participant%20Summary&author=College%20of%20American%20Pathologists&publication_year=2010.(accessed March 31, 2024)."},{"key":"10.1016\/j.revmed.2024.07.008_bib0325","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9343(85)90540-6","article-title":"Evaluation of hyperviscosity in monoclonal gammopathies","volume":"79","author":"Crawford","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2024.07.008_bib0330","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1172\/JCI116178","article-title":"Increased plasma viscosity as a reason for inappropriate erythropoietin formation","volume":"91","author":"Singh","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2024.07.008_bib0335","first-page":"1088","article-title":"Acquired Von Willebrand Disease in Patients with Waldenstr\u00f6m Macroglobulinemia","volume":"130","author":"Castillo","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2024.07.008_bib0340","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1182\/blood-2010-11-297580","article-title":"How I treat the acquired von Willebrand syndrome","volume":"117","author":"Tiede","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2024.07.008_bib0345","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ajh.2830350210","article-title":"Acquired von willebrand disease in multiple myeloma secondary to absorption of von willebrand factor by plasma cells","volume":"35","author":"Richard","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2024.07.008_bib0350","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/jama.1976.03270040048034","article-title":"The hyperviscosity syndrome","volume":"236","author":"Perry","year":"1976","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2024.07.008_bib0355","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3816\/CLML.2010.n.080","article-title":"Beyond the CRAB Symptoms: A Study of Presenting Clinical Manifestations of Multiple Myeloma","volume":"10","author":"Talamo","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.revmed.2024.07.008_bib0360","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2141.1978.tb01077.x","article-title":"Myelomatosis and the Hyperviscosity Syndrome","volume":"38","author":"Preston","year":"1978","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2024.07.008_bib0365","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1172\/JCI106272","article-title":"Aggregation of \u03b3G3\u00a0proteins: relevance to the hyperviscosity syndrome","volume":"49","author":"Capra","year":"1970","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2024.07.008_bib0370","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/0277-5379(91)90020-E","article-title":"Changing clinical presentation of multiple myeloma","volume":"27","author":"Riccardi","year":"1991","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.revmed.2024.07.008_bib0375","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/bmj.289.6457.1539","article-title":"Hyperviscosity syndrome in IgE myeloma","volume":"289","author":"West","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.revmed.2024.07.008_bib0380","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0002-9343(89)90393-8","article-title":"A unique case of kappa light-chain disease associated with cryoglobulinemia, pyroglobulinemia, and hyperviscosity syndrome","volume":"86","author":"Bachrach","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2024.07.008_bib0385","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-2003-44555","article-title":"Hyperviscosity Syndrome in Cryoglobulinemia: Clinical Aspects and Therapeutic Considerations","volume":"29","author":"Rossa","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.revmed.2024.07.008_bib0390","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1182\/blood-2018-07-863787","article-title":"Hyperviscosity syndrome in splenic marginal zone lymphoma","volume":"132","author":"Daniel","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2024.07.008_bib0395","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/1756-185X.12751","article-title":"Hyperviscosity in primary Sj\u00f6gren's syndrome: clinical implications","volume":"20","author":"Hern\u00e1ndez-Molina","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.revmed.2024.07.008_bib0400","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.amjmed.2004.09.011","article-title":"Hyperviscosity syndrome in an HIV-1\u2014positive patient","volume":"117","author":"Garderet","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2024.07.008_bib0405","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s100670200020","article-title":"Hyperviscosity Syndrome in Rheumatoid Arthritis with Felty's Syndrome: Case Report and Review of the Literature","volume":"21","author":"Zakzook","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2024.07.008_bib0410","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3928\/15428877-20100929-10","article-title":"Ocular Findings in a Patient with Castleman's Disease Before and After Treatment with Immunosuppression and Plasmapheresis","volume":"41","author":"Jorge","year":"2010","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.revmed.2024.07.008_bib0415","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/ejh.12059","article-title":"IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy","volume":"90","author":"Wong","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.revmed.2024.07.008_bib0420","first-page":"A3424","article-title":"Hyperviscosity Syndrome: A Rare Cause of Multisystem Organ Dysfunction. B46. Critical care case reports: Hematology, Oncologu","author":"Baskind","year":"2018","journal-title":"Rheumatol Immunol Am Thorac Soc"},{"key":"10.1016\/j.revmed.2024.07.008_bib0425","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM196009222631202","article-title":"Treatment of Waldenstrom's macroglobulinemia by plasmapheresis","volume":"263","author":"Schwab","year":"1960","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2024.07.008_bib0430","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00134-022-06793-z","article-title":"Plasma exchange in the intensive care unit: a narrative review","volume":"48","author":"Bauer","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.revmed.2024.07.008_bib0435","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.amjmed.2010.01.022","article-title":"Practical Considerations for Planning a Therapeutic Apheresis Procedure","volume":"123","author":"Shelat","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2024.07.008_bib0440","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/jca.21529","article-title":"Plasma exchange in the intensive care unit: Technical aspects and complications","volume":"32","author":"Lemaire","year":"2017","journal-title":"J Clin Apher"},{"key":"10.1016\/j.revmed.2024.07.008_bib0445","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.revmed.2024.07.008_bib0450","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.transci.2016.01.003","article-title":"Adverse events in apheresis: An update of the WAA registry data","volume":"54","author":"M\u00f6rtzell Henriksson","year":"2016","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.revmed.2024.07.008_bib0455","first-page":"234","article-title":"Using the World Apheresis Association Registry Helps to Improve the Treatment Quality of Therapeutic Apheresis","volume":"48","author":"Stegmayr","year":"2021","journal-title":"TMH"},{"key":"10.1016\/j.revmed.2024.07.008_bib0460","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/bjh.12102","article-title":"Response assessment in Waldenstr\u00f6m macroglobulinaemia: update from the VIth International Workshop","volume":"160","author":"Owen","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2024.07.008_bib0465","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMc1506192","article-title":"MYD88\u00a0Mutations and Response to Ibrutinib in Waldenstr\u00f6m's Macroglobulinemia","volume":"373","author":"Treon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2024.07.008_bib0470","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/annonc\/mdh403","article-title":"Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom's macroglobulinemia","volume":"15","author":"Treon","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.revmed.2024.07.008_bib0475","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1182\/blood.V116.21.2870.2870","article-title":"The Rituximab and IVIG Related IgM Flare In Waldenstrom's Macroglobulinemia Is Associated with Monocytic Activation of Fcgriia Signaling, and Triggering of IL-6\u00a0Release by the PI3K\/AKT and MAPK Pathways","volume":"116","author":"Yang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2024.07.008_bib0240","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324007069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324007069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T11:43:11Z","timestamp":1733485391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866324007069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0248866324007069"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2024.07.008","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Le syndrome d\u2019hyperviscosit\u00e9 s\u00e9rique\u00a0: mise au point en 2024","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2024.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}